Screens for cytostasis/cytoxicity have considerable value for the discovery of therapeutic agents and the investigation of the biology of apoptosis. For instance, genetic screens for proteins, protein fragments, peptides, RNAs, or chemicals that kill tissue culture cells may aid in identifying new cancer therapeutic targets. A microplate assay for cell death is needed to achieve throughputs sufficient to sift through thousands of agents from expression or chemical libraries. The authors describe a homogeneous assay for cell death in tissue culture cells compatible with 96-or 384-well plates. In combination with a previously described system for retroviral packaging and transduction, nearly 6000 expression library clones could be screened per week in a 96-well plate format. The screening system may also prove useful for chemical screens. (Journal of Biomolecular
INTRODUCTION
A LTHOUGH PROCEDURES EXIST TO SELECT FOR AGENTS that induce cytostasis, 1,2 only a handful of attempts to screen celllethal clones from expression libraries have been reported. [3] [4] [5] Throughputs are often a key issue in such experiments. To ensure identification of rare species, assays should have the capacity to screen large numbers of clones or chemicals. Thus, a microplate cell-lethal assay using cultured cells provides an important tool for identifying transdominant agents and, hence, potential cancer drug targets. In addition, such technology may be applicable to standard chemical screens such as the one developed at the National Cancer Institute (http://dtp.nci.hih.gov/branches/btb/ivclsp.html).
Ideally, an assay for agents that induce cell death should yield 2 pieces of data: (1) dead cell number and (2) total cell number. In this case, cells can be examined at a single time point after transfection, transduction, or chemical administration, allowing identification of agents that kill at different rates. Depending on the assay time point, rapid induction of cell death may generate a large decline in total cell number but a smaller detectable effect on dead cell number (due to the small number of remaining cells in the well). In contrast, a slow-acting agent may produce little effect on total cell number but a significant increase in dead cells. Thus, an assay that measures both dead and total cell counts is potentially more comprehensive than assays that measure only 1 parameter.
In this report, we describe a microplate assay for cell death using cultured cells. The assay is homogeneous, inexpensive, easily automated, and capable of yielding data for both dead cell and total cell numbers. It produces excellent signal-to-noise ratios in both 96-and 384-well formats for several different cell lines. Combined with a previously described system of microplate retroviral packaging and transduction, 6 approximately 6000 individual library expression clones can be screened for cell-lethal activity per week in a 96-well plate format. The assay can also detect chemical-induced cell death, with some advantages over other methods.
MATERIALS AND METHODS

Cells
All cells were cultured at 37°C and 5% CO 2 . HMEC cells were purchased from Clonetics (Walkersville, MD). HMEC cells were maintained in DFCI-1 (32). HEK293 and HT29 cells were purchased from ATCC (Manassas, VA). HT29 cells were maintained in McCoy's media (Life Technologies, Gaithersburg, MD) with 10% fetal calf serum (Hyclone, Logan, UT). HEK293 cells were maintained in DMEM (Life Technologies) with 10% fetal calf serum. The retroviral packaging cell, 293 gp, was a gift from Dr. Inder Verma (Salk Institute, CA). Those cells were maintained in DMEM with 10% fetal calf serum and 200 µg/mL blasticidin (ICN Biomedicals, Costa Mesa, CA).
Plasmids
Plasmid pVT1515 is an MMLV-based retroviral packaging plasmid with hygromycin selection based on pBabe, a gift from Dr. Inder Verma. The pVT1515 plasmid drives expression of the hygromycin resistance gene from a retroviral long terminal repeat (LTR) and the expression of the inserted gene of interest using an internal cytomegalovirus (CMV) promoter. In addition, the pVT1515 contains a nonfluorescent version of EGFP (dEGFP) that is used as a scaffold for C-terminal fusions cloned into tandem, directional Sfi I sites. Cad5CD plasmid was recovered from a cDNA library constructed in pVT1515 using a transdominant screen for molecules that inhibit reporter activity. The cadherin 5derived cDNA insert fused to dEGFP contains the 95 C-terminal amino acids of cadherin 5. TcfDN plasmid is based off a backbone plasmid similar to pVT1515, except that the hygromycin resistance gene is replaced by a neomycin resistance gene. The Tcf4B∆30 insert, missing the first 30 amino acids of the N-terminus, was created from a full-length cDNA copy of Tcf4B by PCR with primers containing Sfi I sites. The insert was then subjected to digestion with Sfi I and ligated into Sfi I-digested backbone vector in frame with dEGFP.
Plasmid pVT1599 is a retroviral packaging plasmid based off of pMFG and drives expression of dEGFP and any cDNA fused to the C terminus. The expression of dEGFP-cDNA fusion is driven by a CMV promoter containing Tat transcriptional activator sequences. 7 The Bid plasmid, isolated from a transdominant screen for cell death, was created in pVT1599 and contains the Bidderived cDNA fragment encoding the 168 C-terminal amino acids fused to the C terminus of dEGFP. Plasmids 158E01 and 178F09 were isolated from the same cDNA fragment library during the same transdominant screen for cell death in which the Bid clone was isolated.
VSVg plasmid, which expresses the vesicular stomatitis virus G envelope protein and is cotransfected with a plasmid of interest during viral packaging, was a gift from Dr. Inder Verma.
Retrovirus packaging and transduction
Packaging of the recombinant retrovirus was done in the 96well plate format in 293 gp cells with the assistance of an automated 96-channel pipettor (Beckman Multimek, Beckman Coulter Instruments, Fullerton, CA). Briefly, a total of 350 ng of purified plasmid DNA (1:1.5 weight ratio, plasmid of interest: VSVg plasmid) was mixed with 1 µL TransIT 293 transfection reagent (Panvera, Madison, WI) and added to 180 µL of 293 gp cells seeded 24 h prior to transfection at 22,500 cells/well in poly-Dlysine-coated 96-well plates (Biocoat plates, Becton-Dickinson, Bedford, MA). The final volume in the well after transfection was 200 µL. The following day, the medium was changed to produce a final volume of 100 µL. After an additional 24-h incubation at 37°C , the supernatant was harvested, pooled, filtered through a 0.45 µ filter, and aliquoted back into 96-well plates for transduction.
To perform 96-well plate transductions with the retroviral supernatant, 84 µL of viral supernatant was combined with 100 µL of cells seeded the previous day in black plastic-walled, clearbottom 96-well plates (Greiner Labortechnik, Germany). The seeding density of the plates varied, depending on the cell type, and was determined empirically as the density that would produce an approximately 80% confluent culture by 6 days posttransduction. The number of seeded cells was as follows: HT29 = 500 cells/well, HMEC = 2000 cells/well, and HEK293 = 300 cells/well. Polybrene was also added to the transduction to a final concentration of 4 µg/mL. Approximately 16 hours posttransduction, the media were changed, and incubation was allowed to continue at 37°C.
To perform 384-well plate transductions, 400 HT29 cells were seeded the previous day into each well of a 384-well black plastic, clear-bottom microplate (Greiner Labortechnik, Germany) in a total volume of 20 µL. On the day of transduction, 20 µL of retroviral supernatant was added to each well in the presence of 4 µg/mL polybrene. The day following transduction, the media were changed and replaced with 45 µL media.
Cytotoxicity/cytostasis assay
Five days posttransduction, Sytox Orange (Molecular Probes, Eugene OR) was added to each well of the assay plate to a final concentration of 1 µM. The plates were allowed to incubate for 30 min at 37°C, and then the fluorescence was read on a CCD imaging system (Ex: 535 ± 15 nm, Em: 585 ± 20 nm).
The imaging system was composed of a PixelVision SpectraVideo™ Series imaging camera (1100 × 330 backilluminated array; PixelVision, Tigurd, OR), PixelVision PixelView™ 3.03 software, two 50-mm/f2 Olympus macro focusing lenses mounted front to front, four 20750 Fostec xenon light sources (Schott-Fostec, Auburn, NY), four 8589 Fostec light lines, a 4457 Daedal stage (Parker Hannifin Corp., Cleveland, OH), and supporting mechanical fixtures. Mechanical fixtures were constructed to position the PixelVision camera below a microtiter dish. In addition, the fixtures mounted the 4 Fostec light lines and allowed the excitation light to be focused on the viewed area of the microtiter dish. A 510-nm filter was placed between the 22 lenses. The front-to-front lens configuration provides 1:1 magnification and close placement of the target object to the imaging system.
After reading, the plates were returned to 37°C incubation. On the 6th day posttransduction, the fluorescence was read again on the CCD. After this read, saponin was added to each well to a final concentration of 0.1%, mixed, and incubated for approximately 2 h at 37°C. The fluorescence of each well was then read again on the CCD.
Fluorescent data analysis-specifically, the number of fluorescent cells and the total fluorescence in the well-was performed using software written in-house. The software image-processing algorithms were as follows.
For circle (well) finding. Using hardware-predicted well location (x, y, r) and a user-selected delta (± d), search the combination of all possible x, y, and r to find the one with the largest (if the wells are darker than the rest of the plate) or the smallest (if the wells are lighter than the rest of the plate) ratio of the mean of outer ring/ mean of inner ring. Mean of ring is defined as the mean intensity of the circle whose center is at (x, y) and whose radius is from r -1 to r + 1.
For dead cell number. 1) Scan the pixels line by line inside of the circle found above. 2) When a "bright" pixel is found, include this pixel as part of this potential cell. 3) Search the neighboring pixels of this cell and include the bright pixels as part of this cell. 4) Repeat step 2 until no more neighboring bright pixels can be found. 5) Reject possible cells that are either too big or too bright.
For total cell number. Relative total cell number was estimated by 1 of 2 ways:
1. Mean pixel fluorescence intensity: average the intensities of the pixels inside of the circle found above. 2. Bright pixel count: sum the number of pixels with fluorescence intensity above background within the circle.
Mean pixel fluorescence intensity yielded better results at higher cell confluencies, whereas bright pixel count yielded more sensitive measurements at lower cell confluencies.
Chemosensitization cytotoxicity/cytostasis assay
To perform the cytotoxicity/cytostasis assay in the presence of chemotherapy drugs, the entire transfection/transduction assay procedure remained the same with the exception that the chemotherapy drug was added with the media during the media change following the transduction. The concentration of chemotherapy drug (methotrexate or cisplatin) used in the assay was predetermined as the highest concentration in cell media that produced dead cell numbers and total cell numbers in the assay statistically indistinguishable from negative control-transduced cells grown without drug. Using HT29 cells, the concentration for methotrexate was 0.0125 µg/mL and for cisplatin was 0.2 µg/mL.
384-well retrovirus packaging
Packaging cells (293 gp) were seeded into gelatin-coated wells of a 384-well plate (Nunc, Naperville, IL) using 7500 cells/well in 20 µL. After culturing for approximately 6 h, the transfection complexes were added. The transfection complex consisted of a total of 40 ng of plasmid DNA (1:1.5 weight ratio of pMFG-based plasmid:VSVg) complexed with Transit 293 (Panvera, Madison, WI). Transit 293 was added at a ratio of 2 µL per 1 µg of total DNA. Formation of DNA-Transit complexes proceeded as prescribed by the manufacturer. The Transit/DNA mixture was added to the cells in a total of 5 µL, making the total volume in the well 25 µL. No media change was necessary the day following transfection. Fortyeight hours after transfection, the supernatants were harvested and used for transductions, as described previously.
For comparison of retroviral packaging efficiency in a 384-well format with a 96-well format, the plasmid transfected was a pMFG-based packaging vector, pVT1598, which contained a copy of Zoanthus green fluorescent protein (zFP) (Clontech, Palo Alto, CA), driven by an HIV2 Tat-responsive promoter. 7 The use of ZFP as a reporter allowed the transduced HT29 cells to be read on the FACS machine to quantify the percentage of cells transduced, as well as the level of fluorescence, which directly correlates with the level of expression of the reporter.
RESULTS
Cytostasis/cytotoxicity bioassay
We sought to create an assay for cell death and cell cycle arrest compatible with retroviral delivery of expression constructs. We therefore took advantage of a system for retroviral transduction that uses robots to manipulate cells and retroviral expression vectors in 96-well microplates. 6 This system, called Somata, achieves low backgrounds and reproducible high expression levels of transduced genes by transduction of relatively small cell numbers (e.g., 3000 cells) with high titers of recombinant retroviral particles. 6 To this Somata system, we appended a detection module for cell death. As readout, 2 parameters were measured for each well: 1) the number of dead/dying cells and 2) the total number of cells. To quantify dead/dying and total cell numbers, a fluorescent dye (Sytox) that stains DNA but does not permeate intact membranes was applied to the cultured cells. In the absence of additional treatment, dead/dying cells were bright and live cells remained dim. A CCD camera image of the plate was analyzed using software that counted bright cells. Total cell numbers, including dying cells, were determined by treating cells with a detergent (Saponin) to permeabilize membranes after the addition of Sytox.
To test the system, known numbers of HEK293 cells, stained with Sytox in the presence of detergent, were sorted into microplate wells and counted. Analysis of these data revealed accuracy, sensitivity, and reproducibility in the assay based on the linear response, low standard deviations, and the ability to count small numbers of cells ( Fig. 1A,B ). Next, known numbers of the Saponin-permeabilized Sytox-stained HEK293 cells were placed into wells of a 96-well plate, and total fluorescence was recorded on a fluorescence plate reader (Fig. 1C) . The results of this experiment demonstrated that the assay had a good dynamic range and a linear correlation between total cell number and total well fluorescence.
Assays for the cell-lethal effects of specific clones
As an initial test of whether the assay could detect an elevated number of dead cells in real transduction experiments, we examined 4 different cytotoxic clones. The first test involved Bid, a powerful inducer of cell death, overexpressed from a retrovirustransduced gene. 8 For comparison, the expression vector without the Bid-encoding sequence was used as a negative control. Results of these experiments demonstrated that the assay detected elevated numbers of dead cells with a reasonable dynamic range and low backgrounds ( Fig. 2A,B) .
High-Throughput Cell-Lethal Assay
We next explored the effects in our assay system of known Tcfand cadherin-derived inhibitors of β-catenin-stimulated transcription. [9] [10] [11] Tcf and cadherin are members of the APC/β-catenin path-way thought to be essential for growth in certain tumor cells. We used the HT29 colon carcinoma cell line that contains inactivating mutations in APC (and hence a constitutively activated β-catenin pathway). The expressed products consisted of a C-terminal fragment of Tcf4 (638 aa, TcfDN) and the cytoplasmic domain of cadherin 5 (95 aa, Cad5CD) fused to the C-terminus of a nonfluorescent version of Aequorea victoriae green fluorescent protein (dEGFP). 12 Measurements of dead cell numbers and total cell numbers were collected (Fig. 3A,B) . These data showed that the signal range was broad, with~10% coefficient of variation (CV). Both clones displayed increased dead cell numbers and decreased total cells compared to the pVT515 control. Thus, as for Finally, a cell-lethal clone (158E01) isolated from the same transdominant genetic screen as the Bid clone, but with a much weaker phenotype, was used in an assay for cell death. As comparison, pVT1599, the base vector without a cDNA fragment fused to the C terminus of dEGFP, was included. As shown in Figure 3C , 158E01 cell-lethal effects were easily distinguished from those of pVT1599 using both dead cell and total cell numbers.
Cytotoxicity/cytostasis assay with chemosensitization
Transdominant agents with cell-lethal phenotypes that synergize with sublethal doses of chemotherapy drugs are of special interest. To aid in the detection of potentially interesting transdominant agents with chemical-enhanced cell-lethal activity, the assay was slightly modified to incorporate a sensitizing dose of chemotherapy agent.
A previously isolated clone with cell-lethal phenotype, 178F09, was assayed for possible synergy with either methotrexate or cisplatin (Fig. 4A,B) . Results plus and minus drug were compared to a control retrovirus (pVT1599). At the doses used, dead cell numbers (graphed in Fig. 4A ) revealed no significant difference in the control (pVT1599-transduced cells) for either methotrexate or cisplatin. In contrast, there were statistically significant effects for 178F09 with both methotrexate and cisplatin. However, total cell numbers, estimated by counting the number of pixels with fluorescence intensity above background (graphed in Fig. 4B ), showed no statistically significant synergy between 178F09 and either methotrexate or cisplatin. Unexpectedly, cisplatin displayed a pro- tective effect on cells transduced with pVT1599, as judged by total cell number.
High-Throughput Cell-Lethal Assay
Comparison of transduction in 384-well and 96-well formats
Assays, especially those that involve mammalian cells, can encounter problems with the scale-down of fluid volumes and cell numbers. Nonetheless, the easiest and cheapest way to increase throughputs is to miniaturize. Therefore, we tested the Somata system in the context of 384-well formats.
The retroviral packaging plasmid (pVT1598), which contains an expression cassette for ZFP, was used to follow the efficiency of packaging and transduction in the 384-well format. The effect of pVT1598 in the 96-well format was used as a standard of comparison. Fluorescence due to ZFP expression was measured on a flow cytometer. Packaging and transduction efficiency were quantified by the percentage of population transduced, mean fluorescence intensity of the population, and percentage of dead cells ( Fig. 5A-C) . For each microplate format, 96 replicate wells were analyzed. There was no significant difference in the packaging and transduction efficiency between the 384-well and 96-well plate format for each parameter measured.
Cytostasis/cytotoxicity bioassay in the 384-well format
We next tested the 384-well format in the context of the cytostasis/cytotoxicity bioassay. Viral supernatants were made in advance, pooled, filtered, and stored frozen as described above. The 2 clones discussed previously (158E01 and 178F09), both of which have more subtle phenotypes than Bid, were used to invoke cell death. The negative control plasmid (pVT1599) was the base vector for 158E01 and 178F09 and expressed dEGFP with no Cterminal cDNA fusion.
Shown in Figure 6 are sample CCD images for an assay performed in the 384-well format with HT29 cells. The images were analyzed using the aforementioned analysis software but with the positions of the wells in each CCD image set manually (Fig. 7) . The assay in the 384-well format yielded a strong signal, particularly considering the far fewer cells involved in the assay. As expected, both 158E01 and 178F09 showed elevated levels of cell death, as well as significantly fewer cells as measured by the total number of bright pixels. However, the %CVs between replicates were considerably worse than those obtained for a 96-well format assay. This may result from the manual manipulation because the assays for the 384-well format were performed by hand with a multichannel pipettor and aspirator. The 96-well experiments were carried out using robots.
DISCUSSION
Although many proteins have been implicated in tumor formation, selective drug targets for cancer are in short supply. Because neoplastic cells are closely related to normal cells, selective cytostasis or cytotoxicity is the key to improved chemotherapeutics. The goal is to characterize candidate drugs and/or drug targets whose inhibition leads either to selective growth arrest or, perhaps more desirably, death of tumor cells.
We developed a microplate assay for cultured cell viability that has several useful features. Addition of Sytox dye to detect dead cells permits homogeneous assay since Sytox in the unbound state is virtually nonfluorescent. Therefore, removal of unbound dye is superfluous. The assay was reproducible and sensitive, enabling detection of small effects on cell growth/death. The microplate format allowed automation and large numbers of replicate assays, further improving the assay's reliability.
Two measurements were made for each well, one for the number of dead/dying cells and one for the total cell number (measured indirectly as total well fluorescence or total number of bright pixels). This allowed detection of cytotoxic as well as cytostatic effects. In addition, the 2 parameters facilitated a more comprehensive analysis of growth effects. For instance, slow-developing lethality might not affect cell numbers significantly but would be apparent in the dead/dying cell count. This may explain the behavior of clone 178F09 in the presence of sensitizing doses of cisplatin and methotrexate. Note that single-cell resolution of the CCD camera is not necessary to capture these 2 types of data. In principle, a bulk measurement such as that from a fluorescence plate reader would be equivalent.
Although the total cell number can be estimated from total well fluorescence, we found that the total number of pixels with fluorescence intensities significantly above a background cutoff value was a more sensitive measure (data not shown). Pixel number also forestalled the possibility of artificially depressed cell counts caused by subsaturating amounts of Sytox dye (data not shown).
On occasion, cell lines used with this assay did not permeabilize well with Saponin. Some cell lines impervious to Saponin could be permeabilized with 0.1% Tween, without any adverse effects in the assay. In fact, Tween generally produced less background fluorescence than Saponin, possibly because Tween lacks the "sticky" carbohydrate moiety that Saponin has. Other detergents may also prove useful in certain cell lines or under specific conditions. Although some of the data shown in this paper were collected using a fluorescence plate reader, we found that the CCD camera was more sensitive than the plate reader. However, the plate reader used here excited and read fluorescence from the top of the plate. Because the assay cells grow as monolayers on the bottom of the well, a bottom-exciting and reading plate reader should be more sensitive for this application. Therefore, it is possible that the detection procedure could be performed on a plate reader, reducing the read and data analysis times. The costs of the 2 devices (custom CCD device and commercial plate reader) are similar, and commercial devices can be purchased with 384-well capability. The cost per well and throughput of the transfection, transduction, and detection modules were improved by adapting the 96-well format protocol to the 384-well format. Specifically, the cost of the transfection reagent per well, the most significant expense in the entire screening process, dropped approximately 10-fold to just over $0.02. Cost of the plasticware per well also improved because 384-well plates cost marginally more than 96-well plates. Read time of the assay on the CCD camera decreased 4fold, whereas the amount of computer disk space used to store the images dropped 4-fold.
The lower cost and higher throughput of the 384-well format assay were accomplished with little effect on the signal range of the assay. Using 158E01 as the benchmark, the dead cell count had a slightly higher signal in the 384-well format than 96-well format (5.8-fold increase over pVT1599 vs. 3.2-fold for 96-well format), whereas total bright pixel count had a lower signal in the 384-well format (1.5-fold decrease below pVT1599 levels vs. 3-fold for 96well format).
The 384-well assay has not yet been automated, but no known obstacles stand in the way. Automation should improve the wellto-well variability, as the pipetting robot can precisely dispense and aspirate without risk of dislodging and removing cells in the wells.
We also showed that the assay-indeed, the entire Somata system-worked in concert with chemical agents. Using 2 different chemotherapeutics (cisplatin and methotrexate), we detected enhancement of apoptotic activity when sublethal doses were used with some cell-lethal clones identified previously ( Fig. 4 and data not shown). The drug screening system at the National Cancer Institute (NCI) involving 60 cell lines may be the best known high-throughput screen for cytostasis/cytotoxicity (http://dtp.nci.hih.gov/ branches/btb/ivclsp.html). This system grows cells in the 96-well format and measures the effects of drugs on total cell number. The system described in this report has some advantages over the NCI assay. First, it is homogeneous and does not require washing steps after addition of dye. Second, it detects dying cells directly and can, therefore, distinguish agents that are cytotoxic from those that are cytostatic. Finally, the dead cell measurement allows detection of agents that act slowly. Even if they produce a negligible effect on total cell number, a significant increase in dying cells can be detected.
CONCLUSIONS
We developed a microplate assay with attractive features for screens of chemical and expression libraries. The assay is simple, homogeneous, and rapid and is compatible with retroviral transduction procedures. Although most data were collected in 96well experiments, we showed that the assay is, in principle, also suited to 384-well formats. This assay system may help in the discovery of cell-lethal agents: expressed proteins, peptides, RNAs, and small-molecule compounds. 
